2,405
Views
161
CrossRef citations to date
0
Altmetric
Review Article

Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine

, , &
Pages 180-196 | Received 30 Mar 2012, Accepted 04 Jan 2013, Published online: 22 Apr 2013

References

  • Agrawal A, Deo R, Wang GD, et al. (2008). Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes. Proc Natl Acad Sci, 105, 3298–303
  • Ahmed MU, Idegami K, Chikae M, et al. (2007). Electrochemical DNA biosensor using a disposable electrochemical printed (DEP) chip for the detection of SNPs from unpurified PCR amplicons. Analyst, 132, 431–8
  • Ahmed MU, Nahar S, Safavieh M, Zourob M. (2013). Real-time electrochemical detection of pathogen DNA using electrostatic interaction of a redox probe. Analyst, 138, 907–15
  • Ahmed MU, Hossain MM, Tamiya E. (2008). Electrochemical biosensors for medical and food applications. Electroanal, 20, 616–26
  • Alivisatos P. (2004). The use of nanocrystals in biological detection. Nat Biotechnol, 22, 47–52
  • Amonkar SD, Bertenshaw GP, Chen T-H, et al. (2009). Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS ONE, 4, e4599
  • Bagalkot V, Zhang L, Levy-Nissenbaum E, et al. (2007). Quantum dot–aptamer conjugates for synchronous cancer imaging, therapy and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett, 7, 3065–70
  • Bertenshaw GP, Yip P, Seshaiah P, et al. (2008). Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev, 17, 2872–81
  • Biris AS, Galanzha EI, Li Z, et al. (2009). In vivo Raman flow cytometry for real-time detection of carbon nanotube kinetics in lymph, blood, and tissues. J Biomed Opt, 14, 021006
  • Boedicker JQ, Li L, Kline TR, Ismagilov RF. (2008). Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics. Lab Chip, 8, 1265–72
  • Broude NE. (2002). Stem-loop oligonucletides: a robust tool for molecular biology and biotechnology. Trends Biotechnol, 20, 249–56
  • Carroll J, Raththagala M, Subasinghe W, et al. (2006). An altered oxidant defense system in red blood cells affects their ability to release nitric oxide-stimulating ATP. Mol Biosyst, 2, 305–11
  • Cha TG, Baker BA, Sauffer MD, et al. (2011). Optical nanosensor architecture for cell-signaling molecules using DNA aptamer-coated carbon nanotubes. ACS Nano, 5, 4236–44
  • Cha T-G, Baker BA, Sauffer MD, et al. (2011). Optical nanosensor architecture for cell-signaling molecules using DNA aptamer-coated carbon nanotubes. ACS Nano, 5, 4236–44
  • Chen FQ, Gerion D. (2004). Fluorescent CdSe/ZnS nanocrystal–peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett, 4, 1827–32
  • Chen Z, Ma L, Liu Y, et al. (2012). Applications of functionalized fullerenes in tumor theranostics. Theranostics, 2, 238–50
  • Clayton TA, Baker D, Lindon JC, et al. (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. PNAS, 106, 14728–733
  • Clayton TA, Lindon JC, Cloarec O, et al. (2006). Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature, 440, 1073–7
  • Colotta F, Mantovani A, Speer R, et al. (2008). Molecular network analysis using reverse phase protein microarrays for patient tailored therapy. Adv Exp Med Biol, 610, 177–86
  • Davis JC, Furstenthal L, Desai AA, et al. (2009). The microeconomics of personalized medicine: today’s challenge and tomorrow's promise. Nat Rev Drug Discov, 8, 279–86
  • De Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J, et al. (2007). Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov, 6, 443–53
  • Defever T, Druet M. (2009). Real-time electrochemical monitoring of the polymerase chain reaction by mediated redox catalysis. J Am Chem Soc, 131, 11433–41
  • Defever T, Druet M. (2011). Real-time electrochemical PCR with a DNA intercalating redox probe. Anal Chem, 83, 1815–21
  • Derfus AM, Chan WCW, Bhatia SN. (2004). Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater, 16, 961–6
  • Dhar M, Griffin M, Hollin I, Kachnowski S. (2012). Innovation spaces: six strategies to inform health care. Health Care Manag, 31, 166–77
  • Dineva MA, Mahilum-Tapay L, Lee H. (2007). Sample preparation: a challenge in the development of point-of-care nucleic acid-based assays for resource-limited settings. Analyst, 132, 1193–9
  • Dubertret B, Skourides P, Norris DJ, et al. (2002). In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science, 298, 1759–62
  • Drummond TG, Hill MG, Barton JK. (2003). Electrochemical DNA sensor. Nat Biotechnol, 21, 10, 1192–9
  • Du D, Zou Z, Shin Y, et al. (2010). Sensitive immunosensor for cancer biomarker based on dual signal amplification strategy of graphene sheets and multienzyme functionalized carbon nanospheres. Anal Chem, 82, 2989–95
  • Emilien G, Ponchon M, Caldas C, et al. (2000). Impact of genomics on drug discovery and clinical medicine. QJM, 93, 391–423
  • Epstein JR, Biran I, Walt DR. (2002). Fluorescence-based nucleic acid detecton and microarrays. Anal Chim Acta, 469, 3–36
  • Epstein JR, Leung APK, Lee KH, Walt DR. (2003). High-density, microsphere-based fiber optic DNA microarrays. Biosens Bioelectron, 18, 541–6
  • Evans WE, Relling MV. (1999). Pharmacogenomics: translating functional genomics into rational therapeutics. Science, 286, 487–91
  • Evans WE, Johnson JA. (2001). Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet, 2, 9–39
  • Espina V, Liotta LA, Petricoin EF. (2009). Reverse-phase protein microarrays for theranostics and patient tailored therapy. Methods Mol Biol, 520, 89–105
  • Fan R, Vermesh O, Srivastava A, et al. (2008). Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nature Biotechnol, 26, 1373–8
  • Fang Z, Kelley SO. (2008). Direct electrocatalytic mRNA detection using PNA-nanowire sensors. Anal Chem, 81, 612–17
  • Fang TH, Ramalingam N. (2009). Real-time PCR microfluidic devices with concurrent electrochemical detection. Biosens Bioelectron, 24, 2131–6
  • Fleck R, Bach D. (2012). Trends in personalized therapies in oncology: the (Venture)Capitalist’s perspective. J Pers Med, 2, 15–34
  • Frank BM, Luke PL. (2008). Innnovations in optical microfluidics technologies for point-of-care diagnostics. Lab Chip, 8, 2015–31
  • Fritz J. (2000). Translating biomolecular recognition into nanomechanics. Science, 288, 316
  • Gao X, Nie S. (2003). Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol, 21, 371–3
  • Gao Z, Agarwal A, Trigg AD, et al. (2007). Silicon nanowire arrays for label-free detection of DNA. Anal Chem, 79, 3291–7
  • Geim AK. (2007). The rise of graphene. Nat Mater, 6, 183–91
  • Gialamas A, Yelland LN, Ryan P, et al. (2009). Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. MJA, 191, 487–91
  • Gibler WB, Blomkalns AL. (2006). Point-of-care testing for cardiac biomarkers in the ED: a blueprint for implementation. Vol. 1. Available from: http://www.emcreg.org/pdf/monographs/POC_Blue06.pdf
  • Goluch ED, Nam JM, Georganopoulou DG, et al. (2006). A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip, 6, 1293–9
  • Goluch ED, Stoeva SI, Lee J-S, et al. (2009). A microfluidic detection system based upon a surface immobilized biobarcode assay. Biosens Bioelectron, 24, 2397–403
  • Goto K, Horiuchi H. (2007). Specific and quantitative detection of PCR products from Clostridium piliforme, Helicobacter bilis, H. hepaticus, and mouse hepatitis virus infected mouse samples using a newly developed electrochemical DNA chip. J Microbiol Methods, 69, 93–9
  • Griffin TJ, Smith LM. (2000). Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. Trends Biotechol, 18, 77–84
  • Gurbel PA, Becker RC. (2007). Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol, 50, 1822–34
  • Gubala V, Harris LF, Ricco AJ, et al. (2012). Point of care diagnostics: status and future. Anal Chem, 84, 487–515
  • Gygi SP, Rochon Y, Franza BR, Aebersold R. (1999). Correlation between protein and mRNA abundance in Yeast. Mol Cell Biol, 19, 1720–30
  • Haile LA. (2008). Making personalized medicine a reality. Vol 28, No.1. Available from: http://www.genengnews.com/gen-articles/making-personalized-medicine-a-reality/2316/
  • Hamburg MA, Collins FS. (2010). The path to personalized medicine. N Engl J Med, 22;363(4):301--4. doi: 10.1056/NEJMp1006304
  • Hill HD, Mirkin CA. (2006). The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nature Protocols, 1, 324–36
  • Ho YP, Leong KW. (2010). Quantum dot-based theranostics. Nanoscale, 2, 60–8
  • Hoggatt J. (2011). Personalized medicine trends in molecular diagnostics: exponential growth expected in the next ten years. Mol Diagn Ther, 15, 53–5
  • Holland CA, Kiechle FL. (2005). Point-of-care molecular diagnostic systems – past, present and future. Curr Opin Microbiol, 8, 504–9
  • Hong SY, Tobias G, Al-Jamal KT, et al. (2010). Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. Nat Mater, 9, 485–90
  • Hughes B. (2009). Developing tools for stratified medicine. Nat Rev Drug Discov, 8, 919–20
  • Issadore D, Min C, Liong M, et al. (2011). Miniature magnetic resonance system for point-of-care diagnostics. Lab Chip, 11, 2282–7
  • Ji J, Manak M. (2002). Genotyping of single nucleotide polymorphisms for epidermiological studies: a review of current methods. J Clin Ligand Assay, 25, 199–210
  • Jokerst NM, Luan L. (2009). Progress in chip-scale photonic sensing. IEEE Trans Biomed Circuits Syst, 3, 202–21
  • Kalow W, Tang BK, Endrenyi I. (1998). Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research. Pharmacogenetics, 8, 283–9
  • Kartalov E, Zhong J. (2006). High-throughput multi-antigen microfluidic fluorescence immunoassays. BioTechniques, 40, 85–90
  • Kent NJ, O’Brien S. (2011). Shear-mediated platelet adhesion analysis in less than 100 μl of blood: toward a POC platelet diagnostic. J IEEE Trans Biomed Eng, 58, 826–30
  • Kerman K, Saito M, Tamiya E. (2008). Electroactive chitosan nanoparticles for the detection of single-nucleotide polymorphisms using peptide nucleic acids. Anal Bioanal Chem, 391, 2759–67
  • Kerman K, Vestergaard MD, Nagatani N, et al. (2006). Electrochemical genosensor based on peptide nucleic acid-mediated PCR and asymmetric PCR techniques: electrostatic interactions with a metal cation. Anal Chem, 78, 2182–9
  • Khan O, Fotheringham S, Wood V, et al. (2010). HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy. Proc Natl Acad Sci, 107, 6532–7
  • Kim MJ, Huang SM, Meyer UA, et al. (2009a). A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. J Clin Pharm, 49, 138–46
  • Kim J, Johnson M, Hill P. (2009b). Microfluidic sample preparation: cell lysis and nucleic acid purification. Integr Biol, 1, 574–86
  • Kingsmore SF. (2006). Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov, 5, 310–21
  • Krishnamoorthy G, Carlen ET, Bomer JG, et al. (2010). Electrokinetic label-free screening chip: a marriage of multiplexing and high throughput analysis using surface plasmon resonance imaging. Lab Chip, 10, 986–90
  • Lee TM, Carles MC, Hsing IM. (2003). Microfabricated PCR-electrochemical device for simultaneous DNA amplification and detection. Lab on a chip, 3, 100–5
  • Lermo A, Zacco E. (2008). Towards Q-PCR of pathogenic bacteria with improved electrochemical double-tagged genosensing detection. Biosens Bioelectron, 23, 1805–11
  • Lesko L. (2008). The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics. Clin Pharmacol Ther, 84, 301–3
  • Liang XJ, Meng H, Wang Y, et al. (2010). Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci USA, 107, 7449–54
  • Lincoln B, Ricco AJ. (2010). Integrated system investigating shear-mediated platelet interactions with von Willebrand factor using microliters of whole blood. Anal Biochem, 405, 174–83
  • Linder V. (2007). Microfluidics at the crossroad with point-of-care diagnostics. Analyst, 132, 1186–92
  • Lisa AH. (2008). Making personalized medicine a reality. Wall Street Bio Beat, 28, 1
  • Liu C, Alwarappan S, Chen Z, et al. (2010). Membraneless enzymatic biofuel cells based on graphene nanosheets. Biosens Bioelectron, 25, 1829–33
  • Liu J, Tiefenauer L, Tian S, et al. (2005). PNA-DNA hybridization study using labeled streptavidin by voltammetry and surface plasmon fluorescence spectroscopy. Anal Chem, 78, 470–6
  • Liu Z, Yang K, Lee, ST. (2011a). Single-walled carbon nanotubes in bio-medical imaging. J Mater Chem, 21, 586–98
  • Liu Z, Robinson JT, Tabakman SM, et al. (2011b). Carbon materials for drug delivery and cancer therapy. Mater Today, 14, 316–23
  • Loh KP, Bao Q, Eda G, et al. (2010). Graphene oxide as a chemically tunable platform for optical applications. Nat Chem, 2, 1015–24
  • Luppa PB, Müller, C, Schlichtiger A. (2011). Point-of-care testing (POCT): current techniques and future perspectives. TrAC Trends Anal Chem, 30, 887–98
  • Mandal HS, Su Z, Ward A, et al. (2012). Carbon nanotube thin film biosensors for sensitive and reproducible whole virus detection. Theranostics, 2, 251–7
  • Mandong G, Yanqing L, Hongxia G, et al. (2007). Electrochemical detection of short sequences related to the hepatitis B virus using MB on chitosan-modified CPE. Bioelectrochemistry, 70, 245–9
  • Marks RS, Lowe CR, Cullen DC, et al. (2007). Handbook of biosensors and biochips. New York: Wiley
  • Margaret et al. (2010). What happened to personalized medicine? Nat Biotechnol, 30, 1. Editorial 2012. doi:10.1038/nbt.2096. Available from: http://www.nature.com/nbt/journal/v30/n1/full/nbt.2096.html
  • Mathivanan S, Ahmed M, Ahn NG, et al. (2008). Human proteinpedia enables sharing of human protein data. Nat Biotechnol, 26, 164–7
  • McDonnell B, Hearty S, Leonard P, et al. (2009). Cardiac biomarkers and the case for point-of-care testing. Clin Biochem, 42, 549–61
  • McLeod HL, Evans WE. (2001). Pharmacogenomics: unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol, 41, 101–21
  • Meng H, Xing G, Sun B, et al. (2010). Potent angiogenesis inhibition by the particulate form of fullerene derivatives. ACS Nano, 4, 2773–83
  • Mitani Y, Lezhava A, Kawai Y, et al. (2007). Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Methods, 4, 257–62
  • Mitani Y, Lezhava A, Sakurai A, et al. (2009). Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research. Pharmacogenomics, 10, 1187–97
  • Nge PN, Rogers CI, Woolley AT. (2013) Advances in microfluidic materials, functions, integration, and applications. Chem Rev, DOI: 10.1021/cr300337x
  • Oh J, Chang YW, Kim HJ, et al. (2010). Carbon nanotube-based dual-mode biosensor for electrical and surface plasmon resonance measurements. Nano Lett, 10, 2755–60
  • Oosta G, Razvi E. (2012). Analysis of miRNA market trends reveals hotspots of research activity. Epigenomics, 4, 237–40
  • Paleček E, Kizek R, Havran L, et al. (2002). Electrochemical enzyme-linked immunoassay in a DNA hybridization sensor. Anal Chim Acta 2002, 469, 73–83
  • Panicco P, Dodhia VR, Fantuzzi A, et al. (2011). Enzyme-based amperometric platform to determine the polymorphic response in drug metabolism by cytochromes P450. Anal Chem, 83, 2179–86
  • Pivonkova H, Horakova P. (2010). Direct voltammetric analysis of DNA modified with enzymatically incorporated 7-Deazapurines. Anal Chem, 82, 6807–13
  • Rana M, Zapf A, Kuehle M, et al. (2012). Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev, 21, 460–6. doi: 10.1097/CEJ.0b013e32834fdb6d
  • Reske T, Mix M. (2007). Electrochemical detection of osmium tetroxide-labeled PCR-products by means of protective strands. Talanta, 74, 393–7
  • Riehemann K, Schneider S, Luger T, et al. (2009). Nanomedicine – challenge and perspectives. Angew Chem Int Ed, 48, 872–97
  • Robinson T, Dittrich PS. (2012). Microfluidic technology for molecular diagnostics. Adv Biochem Eng Biotechnol. DOI: 10.1007/10_2012_139. Springer-Verlag Berlin Heidelberg. Available from: http://link.springer.com/chapter/10.1007%2F10_2012_139
  • Ross P, Hall L, Smirnov I, Haff L, et al. (1998). High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotech, 16, 1347–51
  • Roth M, Keeling P, Smart D. (2009). Driving personalized medicine: capturing maximum net present value and optimal return on investment. Pers Med, 7, 103–14
  • Sabat AJ, Chlebowicz MA, Grundmann H, et al. (2012). Microfluidic-chip-based multiple-locus variable-number tandem-repeat fingerprinting with new primer sets for methicillin-resistant staphylococcus aureus. J Clin Microbiol, 50, 2255–62
  • Safavieh M, Ahmed MU, Tolba M, Zourob M. (2012). Microfluidic electrochemical assay for rapid detection and quantification of Escherichia coli. Biosens Bioelectron, 31, 523–8
  • Sanvicens N, Marco MP. (2008). Multifunctional nanoparticles – properties and prospects for their use in human medicine. Trends Biotechnol, 26, 425–33
  • Sato S, Hokazono K, Irie T, et al. (2006). Ferrocenylnaphthalene diimide-based electrochemical detection of methylated gene. Anal Chim Acta, 578, 82–7
  • Schumacher S, Nestler J, Otto T, et al. (2012). Highly-integrated lab-on-chip system for point-of-care multiparameter analysis. Lab Chip, 12, 464–73
  • Shen J, Zhou Y, et al. (2012). An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders. Lab on a chip, 12, 317–24
  • Shumaker-Parry JS, Aebersold R, Campbell CT. (2004). Parallel, quantitative measurement of protein binding to a 120-element double-stranded DNA array in real time using surface plasmon resonance microscopy. Anal Chem, 76, 2071–82
  • Sista R, Hua Z, Thwar P, et al. (2008). Development of a digital microfluidic platform for point of care testing. Lab Chip, 8, 2091–104
  • Sorger PK. (2008). Microfluidics closes in on point-of-care assays. Nature Biotech, 26, 1345–6
  • Steichen M, Decrem Y, Godfroid E, Buess-Herman C. (2007). Electrochemical DNA hybridization detection using peptide nucleic acids and [Ru(NH3)6]3+ on gold electrodes. Biosens Bioelectron, 22, 2237
  • Stern E, Vacic A, Rajan NK, et al. (2009). Label-free biomarker detection from whole blood. Nature Nanotechnolgy, 5, 138--42
  • Sturgeon CM, Hoffman BR, Chan DW, et al. (2008). National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in clinical practice: quality requirements. Clin Chem, 54, e1–10
  • Subasinghe W, Spence DM. (2008). Simultaneous determination of cell aging and ATP release from erythrocytes and its implications in type 2 diabetes. Anal Chim Acta, 618, 227–33
  • Tantisira KG, Lasky-Su J, Harada M, et al. (2011). Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. N Engl J Med, 365, 1173–83
  • Thaxton CS, Elghanian R, Thomas AD, et al. (2009). Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci, 106, 18437–42
  • Tolan NV, Genes LI, Subasinghe W, et al. (2009). Personalized metabolic assessment of erythrocytes using microfluidic delivery to an array of luminescent wells. Anal Chem, 81, 3102–8
  • Tomizaki KY, Usui K, Mihara H. (2005). Protein-detecting microarrays: current accomplishments and requirements. Chem BioChem, 6, 782–99
  • Tomczak N, Janczewski D, Dorokhin D, et al. (2012). Enabling biomedical research with designer quantum dots. Methods Mol Bio, 811, 245–65
  • Turner APF, Isao K, George S. (1990). Biosensors: fundamentals and applications. Oxford University Press. ISBN-10: 0198547455, ISBN-13: 978-0198547457
  • Turner M, ed. (2011). Embracing change: a pharmaceutical industry guide to the 21st Century. Translational Medicine and Drug Discovery. Cambridge University Press. 328--45. ISBN-13: 9780521886451
  • Wang J. (1999). Towards genoelectronics: Electrochemical Biosensing of DNA hybridization. Chemistry, 5, 1681–5
  • Wang J. (2006). Electrochemical biosensors: towards point-of-care cancer diagnostics. Biosens Bioelectron, 21, 1887–92
  • Wang X, Zhi L, Müllen K. (2008). Transparent, conductive graphene electrodes for dye-sensitized solar cells. Nano Lett, 8, 323–7
  • Weinshilboum RM, Wang L. (2006). Pharmacogenetics and pharmacogenomics: development, science, and translation. Annu Rev Genom Hum G, 7, 223–45
  • Welsher K, Liu Z, Sherlock SP, et al. (2009). A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat Nanotech, 4, 773–80
  • Wu P, Castner DG, Grainger DW. (2008). Diagnostic devices as biomaterials: a review of nucleic acid and protein microarray surface performance issues. J Biomat Sci Polym E, 19, 725–53
  • Wulfkuhle JD, Speer R, Pierobon M, et al. (2008). Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res, 7, 1508–17
  • Yang M, Meng J, Cheng X, et al. (2012). Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis. Theranostics, 2, 258–70
  • Yean CY, Kamarudin B. (2008). Enzyme-linked amperometric electrochemical genosensor assay for the detection of PCR amplicons on a streptavidin-treated screen-printed carbon electrode. Anal Chem, 80, 2774–9
  • Yeo LY, Chang HC, Chan PP, et al. (2011). Microfluidic devices for bioapplications. Small, 7, 12–48
  • Yeung SW, Lee TMH, Cai H, and Hsing IM. (2006). A DNA biochip for on-the-spot multiplexed pathogen identification. Nucleic Acids Res, 34, e118
  • Yu X, Schneiderhan-Marra N, Hsu H-Y, et al. (2009). Protein microarrays: effective tools for the study of inflammatory diseases. Method Mol Biol, 577, 199–214
  • Yu X, Schneiderhan-Marra N, Joos TO. (2010). Protein microarrays for personalized medicine. Clin Chem, 56, 376–87
  • Yum K, Na S, Xiang Y, et al. (2009). Mechanochemical delivery and dynamic tracking of fluorescent quantum dots in the cytoplasm and nucleus of living cells. Nano Lett, 9, 2193–8
  • Zuckerman R, Milne CP. (2012). Market watch: industry perspectives on personalized medicine. Nat Rev Drug Discov, 11, 178–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.